Subscribe
shutterstock_393927661_marbury
marbury / Shutterstock.com
17 August 2021EuropeBeatriz San Martin and Shishu Chen

NHS v Servier: unlawful means tort claim fails, but the long-running saga continues

In this article, we summarise the Supreme Court’s judgment which upholds the lower courts’ decisions in refusing to allow the NHS to avail itself of the tort of unlawful means against Servier, and we comment on the reasoning of the Supreme Court.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English High Court allows Servier to re-amend competition defence against NHS
13 October 2016   The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.


Editor's picks

Bankruptcy judge approves $305m sale of genetics testing company
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025

Editor's picks

Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025

More on this story

Big Pharma
English High Court allows Servier to re-amend competition defence against NHS
13 October 2016   The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.

More on this story

Big Pharma
English High Court allows Servier to re-amend competition defence against NHS
13 October 2016   The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.

More features

Lord Justice Birss to become chancellor of the High Court
Sanofi successfully challenges rare disease patent in Europe
Broad Institute wins appeal to restore CRISPR patent in Europe
AstraZeneca forced to clarify deal terms in row with university
UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
UPC confirms permanent injunction against Curio in 10x tech dispute
Novo Nordisk patent lapse opens door for Canadian Ozempic generics